Lupin Pharmaceuticals Inc. is recalling approximately 14,400 bottles of Cephalexin for Oral Suspension USP 250mg/5 mL, a prescription antibiotic used to treat bacterial infections. The recall was initiated because foreign material was found within the secondary packaging of the sucrose used as an ingredient in the medication. This defect occurred due to deviations from Good Manufacturing Practices (CGMP) during the production process.
The presence of extraneous material during the manufacturing process of an oral medication can lead to physical contamination of the drug, which may pose a risk of ingestion of foreign matter or impact the quality and safety of the final product.
Drug recall baseline remedy
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.